73% of enterprise AI projects exceed their budget by 2x or more. The root cause is not the technology, the team, or the timeline. It is the build vs buy AI decision — and most founders make it using the wrong criteria entirely.
Hayat Amin argues that the standard build vs buy AI decision framework — weighing cost against speed — ignores the single variable that determines long-term defensibility: intellectual property ownership. A founder who builds AI in-house creates patentable assets. A founder who buys off-the-shelf creates a vendor dependency. Both paths cost money. Only one creates an IP moat.
This is the build vs buy AI decision framework Beyond Elevation uses with every client — and it starts with IP, not infrastructure.
What Is the Build vs Buy AI Decision — And Why Does It Determine Your IP Moat?
The build vs buy AI decision is the highest-stakes technology choice a founder makes in 2026. Most founders evaluate cost and speed — but ignore IP ownership, the factor that determines 80% of long-term defensibility. Beyond Elevation frames this decision around one question: will you own the resulting intellectual property?
When you build AI in-house, every novel algorithm, training pipeline, data preprocessing step, and model architecture is potentially patentable. These assets compound over time. They increase your valuation. They create licensing revenue opportunities. They make your company harder to replicate.
When you buy AI from a vendor, you get speed. You get lower upfront cost. But you own nothing proprietary. Your competitor buys the same solution from the same vendor next quarter. You have exchanged long-term defensibility for short-term convenience.
The data is unambiguous: companies with patents are 10.2x more likely to secure early-stage funding. That statistic does not distinguish between good patents and bad patents. It measures defensibility signalling. And the build vs buy AI decision is where that signal is either created or permanently forfeited.
When Should You Build AI In-House? The Build vs Buy AI Decision Checklist
Build AI in-house when your AI capability is your core product differentiation — the thing that makes your business impossible to copy at scale. If your proprietary model, dataset, or inference pipeline is what creates customer value, buying a generic alternative hands your moat to a vendor who sells the same capability to your competitors.
Here are the four conditions that make building the right call:
Your AI is the product. If customers pay for your AI's output — predictions, recommendations, decisions, generated content — then building is non-negotiable. The model IS the asset. Buying it means you do not own your own product.
You have proprietary training data. Proprietary data is the single most defensible AI asset. Building a custom model trained on that data creates a compound advantage no vendor can replicate. The DGS data monetisation deal proved this principle — a data asset most founders thought was worthless became a seven-figure licensing stream once it was properly structured.
Your vertical demands domain-specific performance. Off-the-shelf models underperform in regulated, specialised, or high-stakes verticals. If your customers need 99.5% accuracy instead of 92%, you need custom fine-tuning — and that fine-tuning process is protectable IP.
You plan to license or exit. If your roadmap includes licensing technology to other companies or positioning for acquisition, building creates the patent portfolio and trade secrets that drive premium valuations. Acquirers pay for IP. They do not pay for vendor subscriptions.
When Should You Buy AI Instead of Building? The Build vs Buy AI Cost Reality
Buy AI when the capability is operational infrastructure — not your competitive advantage. Internal tools, customer support automation, document processing, and code generation are categories where off-the-shelf solutions outperform custom builds on cost, speed, and reliability without sacrificing competitive position.
The mistake founders make is buying when they should build. But the opposite mistake — building everything from scratch — is equally expensive and equally common.
Hayat Amin's rule is direct: if no customer would pay a premium because you built it yourself, buy it. Save your engineering capital for the capabilities that create protectable IP.
Three signals that buying is the right call:
The capability is commoditised. If three or more vendors offer the same functionality at competitive prices, building it in-house is a vanity project. The IP value of a commodity capability is zero.
You need it in 30 days, not 12 months. Speed matters when the AI capability is a prerequisite for your actual product — not the product itself. Buy the infrastructure. Build the moat.
Your team lacks ML depth. Hiring and retaining ML engineers costs £150K–£250K per head annually. If you need three engineers for 18 months to build something a vendor sells for £2K per month, the maths does not work — unless the IP created is worth multiples of the investment.
Hayat Amin's Build vs Buy AI Decision Framework
The Hayat Amin Build vs Buy AI Decision Framework is a five-question diagnostic that forces founders to evaluate IP implications before cost implications. Beyond Elevation runs this framework with every client evaluating an AI investment above £100K. Five yes answers mean build. Three or fewer mean buy. Four is the danger zone — and it requires an IP audit before committing.
Question 1: Does this AI capability create a novel, patentable method? If your approach to the problem is genuinely new — a novel architecture, training process, or inference technique — it is patentable. Building creates the IP. Buying forfeits it.
Question 2: Will you own proprietary data that improves over time? Proprietary data that feeds back into model performance creates a flywheel competitors cannot purchase. If yes, build — because the compound advantage grows every month.
Question 3: Would a competitor gain your differentiation by purchasing from the same vendor? If the answer is yes, you have no moat. Build instead.
Question 4: Does your AI moat depend on this specific capability? If the AI capability is upstream of your defensibility — meaning without it, your product becomes replicable — building is the only strategic option.
Question 5: Will the resulting IP increase your valuation at next fundraise or exit? Hayat Amin reminds founders of a number that changes term sheets: companies with patents are 10.2x more likely to secure early-stage funding. If building this AI creates patentable assets, the valuation premium alone justifies the investment.
How Does the Build vs Buy AI Decision Affect Your Valuation?
The build vs buy AI decision directly determines whether your AI investment shows up on your balance sheet as an asset or an expense. Built AI creates patents, trade secrets, and proprietary datasets — intangible assets that investors price into your valuation. Bought AI creates vendor invoices that depreciate your margins. One compounds. The other does not.
The proof is in the exits. When Hayat Amin restructured Position Imaging's 66-patent portfolio, it was not a collection of defensive filings. It was an IP architecture designed for recurring royalty revenue — now generating eight figures annually. That restructuring happened because Position Imaging had built its core technology in-house and created patentable assets at every layer of the stack.
Compare that to an AI startup that buys its core model from a foundation model provider, wraps it in a UI, and calls it a product. The acquirer sees zero proprietary IP. The valuation reflects it: a revenue multiple, not a technology multiple.
The gap between these two outcomes is the build vs buy AI decision made three years earlier.
At Beyond Elevation, we run IP audits before founders commit to either path. The audit maps which capabilities should be built to maximise IP creation and which should be bought to conserve engineering capital. The result is a build vs buy AI decision that creates the most defensible portfolio at the lowest total cost.
If you are making a build vs buy AI decision above £100K, book an IP strategy consultation before you commit. The cost of getting this wrong is not the budget overrun. It is the IP you never created.
FAQ
What is the biggest risk of buying AI instead of building?
The biggest risk is forfeiting IP ownership. When you buy AI from a vendor, you own no patents, no proprietary models, and no trade secrets. Your competitor can purchase the same solution and replicate your capability overnight. Building creates defensible assets; buying creates replaceable expenses.
How much does it cost to build AI in-house vs buying?
Building a custom AI capability typically costs £250K–£750K in the first year, including engineering salaries, compute infrastructure, and data acquisition. Buying ranges from £20K–£150K annually for vendor licences. However, building creates IP assets worth multiples of the investment at exit, while vendor costs are pure expense with no residual value.
When should a startup buy AI instead of building?
Buy when the AI capability is operational infrastructure — not your competitive differentiation. Customer support chatbots, internal document processing, and code generation tools are strong buy candidates. If no customer would pay a premium because you built it yourself, buy it and redirect engineering resources toward capabilities that create protectable, licensable IP.
How does the build vs buy AI decision affect fundraising?
Companies with patents are 10.2x more likely to secure early-stage funding. Building AI in-house creates patentable assets that signal defensibility to investors. Buying AI creates vendor dependencies that signal replaceability. Investors price the difference into your valuation — often at a 2–4x multiple premium for companies with proprietary AI IP.